Dementia Moves: Protocol for a Feasibility Study
Launched by DALHOUSIE UNIVERSITY · May 2, 2024
Trial Information
Current as of May 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Dementia Moves study is looking into a new exercise program designed specifically for residents in long-term care who have moderate to severe dementia. Many people in these facilities struggle with daily tasks due to their condition, and regular exercise can help them maintain their abilities. This program includes a mix of exercises tailored to each person, focusing on balance, strength, and aerobic activities. The goal of this pilot study is to see if it's feasible to implement this program with 16 residents in two homes in Nova Scotia. Researchers will look at factors like how many people join the program, how often they participate, and any challenges faced during the exercise sessions.
To be eligible for the study, participants must have a diagnosis of dementia and show signs of moderate to severe cognitive impairment, as indicated by a specific test score. However, those receiving end-of-life care will not be included. If you or a family member participates, you can expect to engage in a structured exercise routine tailored to individual needs, with the hope of improving daily functioning and overall well-being. This study is still in the planning stages and has not yet started recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. A clinical diagnosis of any form of dementia as documented in their electronic medical record
- • 2. a Mini-Mental State Exam Score (MMSE) of 20 or less, or Cognitive Performance Scale (CPS) Score of 3 or higher, indicating moderate to severe cognitive impairment.
- Exclusion Criteria:
- • Participants who are receiving end of life care in the LTC
About Dalhousie University
Dalhousie University is a leading research institution located in Halifax, Nova Scotia, dedicated to advancing health and wellness through innovative clinical research. With a strong emphasis on multidisciplinary collaboration, the university leverages its diverse expertise in medicine, health sciences, and related fields to conduct high-quality clinical trials aimed at improving patient outcomes. Dalhousie University is committed to ethical research practices and patient safety, ensuring that its studies contribute valuable insights to the scientific community and the broader healthcare landscape. Through its state-of-the-art facilities and a robust network of clinical partnerships, Dalhousie University continues to play a pivotal role in shaping the future of healthcare research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Caitlin McArthur, PhD
Principal Investigator
Dalhousie University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported